You just read:

Eiger Announces PRIME Designation Granted by European Medicines Agency for Lonafarnib for Treatment of Hepatitis Delta Virus Infection

News provided by

Eiger BioPharmaceuticals, Inc.

Dec 18, 2018, 08:00 ET